10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
BRISTOL MYERS SQUIBB CO | |||
Ticker: BMY Fiscal Year: 2011 | |||
CONSOLIDATED STATEMENTS OF EARNINGS | |||
Period Ending Dec 31, 2011 10-K (Filed: Feb 17, 2012) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | |
| Net Sales | $ 21,244 | 19,484 | 18,808 |
| Cost of products sold | 5,598 | 5,277 | 5,140 |
| Marketing, selling and administrative | 4,203 | 3,686 | 3,946 |
| Advertising and product promotion | 957 | 977 | 1,136 |
| Research and development | 3,839 | 3,566 | 3,647 |
| Provision for restructuring | 116 | 113 | 136 |
| Litigation expense, net | (19) | 132 | |
| Equity in net income of affiliates | (281) | (313) | (550) |
| Other (income)/expense | (169) | 126 | (381) |
| Total Expenses | 14,263 | 13,413 | 13,206 |
| Earnings from Continuing Operations Before Income Taxes | 6,981 | 6,071 | 5,602 |
| Provision for income taxes | 1,721 | 1,558 | 1,182 |
| Net Earnings from Continuing Operations | 5,260 | 4,513 | 4,420 |
| Discontinued Operations: | |||
| Earnings, net of taxes | 285 | ||
| Gain on disposal, net of taxes | 7,157 | ||
| Net Earnings from Discontinued Operations | 7,442 | ||
| Net Earnings | 5,260 | 4,513 | 11,862 |
| Net Earnings Attributable to Noncontrolling Interest | 1,551 | 1,411 | 1,250 |
| Net Earnings Attributable to Bristol-Myers Squibb Company | 3,709 | 3,102 | 10,612 |
| Amounts Attributable to Bristol-Myers Squibb Company | |||
| Net earnings from continuing operations attributable to Bristol-Myers Squibb Company | 3,709 | 3,102 | 3,239 |
| Net earnings from discontinued operations attributable to Bristol-Myers Squibb Company | 7,373 | ||
| Earnings per Common Share | |||
| Basic Earnings per Common Share from Continuing Operations Attributable to Bristol-Myers Squibb Company | 2.1800 | 1.8000 | 1.6300 |
| Diluted Earnings per Common Share from Continuing Operations Attributable to Bristol-Myers Squibb Company | 2.1600 | 1.7900 | 1.6300 |
| Basic Earnings Per Common Share Attributable to Bristol-Myers Squibb Company | 2.1800 | 1.8000 | 5.3500 |
| Diluted Earnings per Common Share Attributable to Bristol-Myers Squibb Company | 2.1600 | 1.7900 | 5.3400 |
| Dividends declared per common share | 1.3300 | 1.2900 | 1.2500 |
| External Links | |
| BRISTOL MYERS SQUIBB CO (BMY) Fiscal Year 2011 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |